Lv4
560 积分 2025-05-21 加入
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies
11小时前
已完结
Clinical Effectiveness and Safety of Dupilumab in Chronic Obstructive Pulmonary Disease Patients: A 7-Year Population-based Cohort Study
7天前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
7天前
已完结
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores
7天前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
12天前
已完结
Cytokine production by T-cell clones from bronchoalveolar lavage fluid of patients with asthma and healthy subjects
1个月前
已关闭
Differential requirements for interleukin (IL)‐4 and IL‐13 in protein contact dermatitis induced by Anisakis
1个月前
已关闭
Innate immune regulates cutaneous sensory IL-13 receptor alpha 2 to promote atopic dermatitis
1个月前
已关闭
IL-13 as a therapeutic target for respiratory disease
1个月前
已关闭
Cell-Specific Contribution of IL4 Receptor α Signaling Shapes the Overall Manifestation of Allergic Airway Disease
1个月前
已完结
皖公网安备34019202002308
